New Delhi, April 23: Microplastics and nanoplastics pose a serious threat to liver health, according to new research published in the prestigious Nature Reviews Gastroenterology & Hepatology journal. Scientists confirmed on Thursday, April 23 that exposure to these tiny plastic particles triggers oxidative stress, fibrogenesis, and inflammation in animals — conditions that closely mirror the hallmarks of advanced liver disease in humans. The findings have intensified global concern over plastic pollution as a direct public health crisis.

How Microplastics Reach and Damage the Liver

The liver serves as the human body's primary detoxification organ, filtering everything consumed through food, water, and air. Researchers warn that this makes it especially vulnerable to micro and nanoplastic particles, which can act as carriers for microbial pathogens, antimicrobial resistance determinants, endocrine-disrupting chemicals, and carcinogenic additives.

Once these particles enter the bloodstream, the liver is the first major organ to encounter them. Scientists argue that the liver's role as the body's "gatekeeper" means it absorbs the brunt of plastic-related toxicity — potentially accelerating disease progression in individuals already at risk.

The research team highlighted that plastics have already been shown to accumulate and cause measurable harm in the livers of animals, raising the pointed question of why human biology would respond any differently under comparable exposure conditions.

Lead Researcher Raises Alarm on Global Liver Disease Surge

Professor Shilpa Chokshi, the article's lead author and Professor of Experimental Hepatology and Director of the Centre of Environmental Hepatology, noted that liver disease is rising at an alarming pace worldwide and is now responsible for 1 in every 25 deaths globally.

"While established risk factors such as obesity and harmful alcohol use remain central, they do not fully explain the scale or pace of this increase," said Professor Chokshi. "This has led us to consider additional environmental factors, including micro- and nanoplastics, which may interact with existing disease processes and amplify liver injury."

Chokshi, who has spent over two decades developing therapeutics for liver disease, added: "In an increasingly plastic-laden world, where plastics are closely associated with our food, water, and air, these exposures may not only reach the liver but also interact with existing disease processes and amplify harm."

Critical Research Gaps and Methodological Challenges

Despite the mounting evidence, researchers acknowledged that significant knowledge gaps remain. The review identified critical methodological bottlenecks, unmet research priorities, and technical challenges that are currently hindering the collection of direct evidence linking plastic exposure to liver injury in humans.

The team called for urgent, large-scale studies specifically designed to examine plastic accumulation in human liver tissue and its correlation with disease markers. Current detection technologies and the sheer diversity of plastic types and sizes make standardised research difficult.

This is particularly concerning given that human exposure to microplastics has increased exponentially over the past two decades, with plastics now detected in human blood, lung tissue, placenta, and breast milk — yet liver-specific research remains underfunded and fragmented.

Plastic Pollution: A Global Environmental and Health Emergency

Professor Richard Thompson OBE FRS, Professor of Marine Biology at the University of Plymouth, reinforced the broader implications of the study. "This is further evidence that plastic pollution is, without question, a global environmental and health challenge," he stated.

Thompson's comments carry particular weight — he is widely credited as one of the scientists who first identified and named microplastics as an environmental contaminant, making his endorsement of this research a significant moment in the field.

Notably, this study arrives amid growing international pressure to finalise a Global Plastics Treaty under the United Nations Environment Programme (UNEP), with nations deadlocked over binding production limits. Critics argue that industry lobbying has repeatedly stalled meaningful regulation, even as the health evidence becomes harder to ignore.

What This Means for India and the Path Forward

For India, a country with one of the world's highest burdens of non-alcoholic fatty liver disease (NAFLD) and rapidly growing plastic consumption, the implications are especially urgent. India generates approximately 3.5 million tonnes of plastic waste annually, and enforcement of the 2022 single-use plastic ban remains inconsistent across states.

Public health experts have long warned that India's food supply chain — from street food served in plastic containers to drinking water stored in poorly regulated plastic bottles — creates near-constant microplastic exposure for hundreds of millions of people.

As global scientific consensus hardens around the toxicity of microplastics, pressure will mount on governments, regulatory bodies, and the plastics industry to act. Researchers say the next critical step is establishing standardised biomonitoring protocols for plastic particles in human liver biopsies — a move that could finally provide the definitive human evidence needed to drive binding policy action.